Jade Biosciences, Inc. - COM (AVTE)

Historical Holders from Q2 2021 to Q3 2025

Type / Class
Equity / COM
Symbol
AVTE
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
0
Total reported value
$0
Share change
-24,414
Value change
-$65,395
Avg sell value change
-0%
Number of holders
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, Jade Biosciences, Inc. - COM (AVTE) has 0 institutional shareholders filing 13F forms. They reported no common stock holdings, but disclosed options positions.

Institutional Holders of Jade Biosciences, Inc. - COM (AVTE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 0 $0 -$65,395 0
2025 Q2 24,414 $65,395 -$79,443,845 259.49% 2
2025 Q1 31,698,351 $79,562,845 +$3,810,133 251% 80
2024 Q4 30,167,836 $79,943,386 +$6,829,240 265% 78
2024 Q3 27,643,944 $57,772,391 +$1,542,803 209% 74
2024 Q2 27,181,632 $45,121,455 -$188,977,629 166% 83
2024 Q1 28,456,703 $841,465,768 +$13,166,269 2,957% 80
2023 Q4 13,580 $307,315 2,263% 1
2023 Q3 28,465,427 $386,276,038 -$1,301,763 1,357% 58
2023 Q2 28,473,066 $488,311,096 +$39,095,572 1,715% 60
2023 Q1 25,984,813 $524,111,618 -$46,644,865 2,017% 65
2022 Q4 27,398,502 $802,773,708 +$18,072,249 2,930% 67
2022 Q3 26,977,893 $447,288,690 +$20,306,767 1,657.99% 52
2022 Q2 25,761,396 $402,650,000 -$2,397,893 1,562.99% 45
2022 Q1 25,923,834 $475,187,000 +$8,604,934 1,833.02% 42
2021 Q4 25,576,906 $301,501,000 -$15,335,690 1,178.99% 46
2021 Q3 21,654,813 $452,572,000 +$35,117,476 2,097.97% 41
2021 Q2 19,965,251 $454,425,000 +$454,424,870 2,283% 17